CAMBRIDGE, Mass., May 24, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present company overviews at three upcoming investor conferences in June:

• Goldman Sachs 37th Annual Global Healthcare Conference on Wednesday, June 8, 2016 at 4:00 p.m. PT (7:00 p.m. ET) in Rancho Palos Verdes, Calif.
   
• Jefferies 2016 Healthcare Conference on Thursday, June 9, 2016 at 4:30 p.m. ET in New York City
   
• JMP Securities 2016 Life Sciences Conference on Tuesday, June 21, 2016 at 11:00 a.m. ET in New York City

A live webcast of each presentation will be available on the Investors & Media section of the Editas website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following the presentation.
                                         
About Editas Medicine
Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes. The Company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.

Media Contact 
Dan Budwick

Pure Communications, Inc.

(973) 271-6085
dan@purecommunicationsinc.com

Investor Contact
Jesse Baumgartner
Stern Investor Relations, Inc.
(212) 362-1200
jesse@sternir.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.